Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06633224 · ClinicalTrials.gov registry record
Fatigue and Molecular Mechanisms in Cancer Patients Receiving CCRT
A clinical trial of Cancer and Head and Neck Cancer, sponsored by University of California, San Francisco.
- Recruiting
- Registry status
- 125
- Enrollment target
- 1
- Study location
NCT06633224 is a study of Cancer and Head and Neck Cancer that is actively recruiting participants, run by University of California, San Francisco. The registered enrollment target is 125 participants, below the 3,491-participant average among 615 other Cancer trials with a reported enrollment target (96% lower). The trial reports 1 study location across 1 state.
The verdict
NCT06633224, a study of Cancer and Head and Neck Cancer, is actively recruiting participants, sponsored by University of California, San Francisco.
- RECRUITING
- Registry status
- 125 participants
- Enrollment target
- 1
- Study location
Study Summary
Cancer-related fatigue (CRF) is a significant problem for cancer patients. This prospective, basic science, observational study will evaluate for changes in CRF associated with molecular characteristics prior to, during, and at the completion of non-investigational, standard-of-care, combined chemotherapy and radiation therapy (CCRT) and to develop and assess predictive models for CRF severity.
Conditions Studied
Interventions
- PROCEDURE Blood Specimen Collection
- OTHER Stool Specimen Collection
- OTHER Quality of Life (QOL) Questionnaires
Study Locations (1)
California
- University of California, San Francisco - San Francisco
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 125 participants |
| Start Date | 2024-12-27 |
| Est. Completion | 2027-09-01 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06633224
The ClinicalTrials.gov registry entry for NCT06633224 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 125 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 3,491-participant average among 615 other Cancer trials with a reported enrollment target (96% lower). The listed sponsor is University of California, San Francisco, which has 1,713 total studies on file at ClinicalTrials.gov.
The record links to 5 conditions, with Cancer appearing as the primary indexed condition, and to 3 interventions - of which Blood Specimen Collection is the first listed.
NCT06633224 reports 1 study location spanning 1 distinct geographic area - top geographies include California.
Frequently Asked Questions
What is clinical trial NCT06633224 about?
NCT06633224 is a clinical study titled "Fatigue and Molecular Mechanisms in Cancer Patients Receiving CCRT". Cancer-related fatigue (CRF) is a significant problem for cancer patients. This prospective, basic science, observational study will evaluate for changes in CRF associated with molecular characteristics prior to, during, and at the completion of non-investigational, standard-of-care, combined chemot...
What is the current status of trial NCT06633224?
This trial is currently recruiting. The enrollment target is 125 participants. The study started on 2024-12-27. Estimated completion is 2027-09-01.
What conditions does trial NCT06633224 study?
This clinical trial studies the following conditions: Cancer, Head and Neck Cancer, Gynecologic Cancer, Gastrointestinal Cancer, Thoracic Cancer.
What interventions are being tested in trial NCT06633224?
The interventions under investigation include: Blood Specimen Collection (PROCEDURE), Stool Specimen Collection (OTHER), Quality of Life (QOL) Questionnaires (OTHER).
Who is sponsoring clinical trial NCT06633224?
This trial is sponsored by University of California, San Francisco, which has 1,713 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06633224 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Registry Study to Evaluate the Clinical Outcome of Cancer Patients and Benign Diseases Treated with Radiation
RECRUITING
-
Treatment of Immune Checkpoint Inhibitor-related Diarrhea and/ or Colitis With Ustekinumab in Cancer Patients
RECRUITING · Phase 2
-
IMPACT (IMproving Proactive Approaches for Cancer Survivors' Mental Health Treatment)
RECRUITING · NA
-
A Natural History Study of Metabolic Sizing in Health and Disease
RECRUITING
-
Development of Radiation Free Whole Body Magnetic Resonance (MR) Imaging Technique for Staging Children With Cancer
RECRUITING · Phase 1
-
Long-Term Follow-Up of Recipient of Gene Transfer Research
RECRUITING
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.